These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34147544)

  • 1. PepBiotics, novel cathelicidin-inspired antimicrobials to fight pulmonary bacterial infections.
    van Eijk M; van Dijk A; van der Ent CK; Arets HGM; Breukink E; van Os N; Adrichem R; van der Water S; Lino Gómez R; Kristensen M; Hessing M; Jekhmane S; Weingarth M; Veldhuizen RAW; Veldhuizen EJA; Haagsman HP
    Biochim Biophys Acta Gen Subj; 2021 Sep; 1865(9):129951. PubMed ID: 34147544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds.
    van Eijk M; Boerefijn S; Cen L; Rosa M; Morren MJH; van der Ent CK; Kraak B; Dijksterhuis J; Valdes ID; Haagsman HP; de Cock H
    Med Mycol; 2020 Nov; 58(8):1073-1084. PubMed ID: 32236485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insights in antimicrobial and immunomodulatory mechanisms of action of PepBiotics CR-163 and CR-172.
    van Os N; Javed A; Broere F; van Dijk A; Balhuizen MD; van Eijk M; Rooijakkers SHM; Bardoel BW; Heesterbeek DAC; Haagsman HP; Veldhuizen E
    J Glob Antimicrob Resist; 2022 Sep; 30():406-413. PubMed ID: 35840108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.
    Geitani R; Ayoub Moubareck C; Touqui L; Karam Sarkis D
    BMC Microbiol; 2019 Mar; 19(1):54. PubMed ID: 30849936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity of mammalian cathelicidin-derived peptides.
    Travis SM; Anderson NN; Forsyth WR; Espiritu C; Conway BD; Greenberg EP; McCray PB; Lehrer RI; Welsh MJ; Tack BF
    Infect Immun; 2000 May; 68(5):2748-55. PubMed ID: 10768969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia.
    Pompilio A; Crocetta V; Scocchi M; Pomponio S; Di Vincenzo V; Mardirossian M; Gherardi G; Fiscarelli E; Dicuonzo G; Gennaro R; Di Bonaventura G
    BMC Microbiol; 2012 Jul; 12():145. PubMed ID: 22823964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial properties of membrane-active dodecapeptides derived from MSI-78.
    Monteiro C; Fernandes M; Pinheiro M; Maia S; Seabra CL; Ferreira-da-Silva F; Costa F; Reis S; Gomes P; Martins MC
    Biochim Biophys Acta; 2015 May; 1848(5):1139-46. PubMed ID: 25680229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial, anti-biofilm and in vivo activities of the antimicrobial peptides P5 and P6.2.
    Martínez M; Polizzotto A; Flores N; Semorile L; Maffía PC
    Microb Pathog; 2020 Feb; 139():103886. PubMed ID: 31778756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel, rationally designed, hybrid antimicrobial peptide, inspired by cathelicidin and aurein, exhibits membrane-active mechanisms against Pseudomonas aeruginosa.
    Klubthawee N; Adisakwattana P; Hanpithakpong W; Somsri S; Aunpad R
    Sci Rep; 2020 Jun; 10(1):9117. PubMed ID: 32499514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly selective end-tagged antimicrobial peptides derived from PRELP.
    Malmsten M; Kasetty G; Pasupuleti M; Alenfall J; Schmidtchen A
    PLoS One; 2011 Jan; 6(1):e16400. PubMed ID: 21298015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core-shell magnetic nanoparticles display synergistic antibacterial effects against
    Niemirowicz K; Piktel E; Wilczewska AZ; Markiewicz KH; Durnaś B; Wątek M; Puszkarz I; Wróblewska M; Niklińska W; Savage PB; Bucki R
    Int J Nanomedicine; 2016; 11():5443-5455. PubMed ID: 27799768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate.
    Bucki R; Leszczynska K; Byfield FJ; Fein DE; Won E; Cruz K; Namiot A; Kulakowska A; Namiot Z; Savage PB; Diamond SL; Janmey PA
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2525-33. PubMed ID: 20308375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing the antibacterial activity of antimicrobial peptide PMAP-37(F34-R) by cholesterol modification.
    Chen L; Shen T; Liu Y; Zhou J; Shi S; Wang Y; Zhao Z; Yan Z; Liao C; Wang C
    BMC Vet Res; 2020 Nov; 16(1):419. PubMed ID: 33138816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients.
    Pompilio A; Scocchi M; Pomponio S; Guida F; Di Primio A; Fiscarelli E; Gennaro R; Di Bonaventura G
    Peptides; 2011 Sep; 32(9):1807-14. PubMed ID: 21849157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Antibacterial and Anti-inflammatory Activity of Chicken Cathelicidin-2 combined with Exogenous Surfactant for the Treatment of Cystic Fibrosis-Associated Pathogens.
    Banaschewski BJH; Baer B; Arsenault C; Jazey T; Veldhuizen EJA; Delport J; Gooyers T; Lewis JF; Haagsman HP; Veldhuizen RAW; Yamashita C
    Sci Rep; 2017 Nov; 7(1):15545. PubMed ID: 29138462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models.
    Li SA; Lee WH; Zhang Y
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3309-17. PubMed ID: 22491685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.
    Saiman L; Tabibi S; Starner TD; San Gabriel P; Winokur PL; Jia HP; McCray PB; Tack BF
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2838-44. PubMed ID: 11557478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid selectivity in novel antimicrobial peptides: Implication on antimicrobial and hemolytic activity.
    Maturana P; Martinez M; Noguera ME; Santos NC; Disalvo EA; Semorile L; Maffia PC; Hollmann A
    Colloids Surf B Biointerfaces; 2017 May; 153():152-159. PubMed ID: 28236791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial peptide therapeutics for cystic fibrosis.
    Zhang L; Parente J; Harris SM; Woods DE; Hancock RE; Falla TJ
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2921-7. PubMed ID: 15980369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antibacterial activity of BF-30 in vitro and in infected burned rats is through interference with cytoplasmic membrane integrity.
    Zhou H; Dou J; Wang J; Chen L; Wang H; Zhou W; Li Y; Zhou C
    Peptides; 2011 Jun; 32(6):1131-8. PubMed ID: 21515321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.